WVE - Why Cerevel Therapeutics Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket | Benzinga
Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) jumped in pre-market trading after AbbVie Inc. (NYSE: ABBV) announced it will acquire the company for a total equity value of approximately $8.7 billion.
AbbVie will acquire all outstanding shares of Cerevel for $45 per share in cash, with the transaction anticipated to close in the middle of 2024.
Cerevel Therapeutics shares rose 14.7% to $42.35 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Hempacco Co., Inc. (NASDAQ: HPCO) shares gained 75.3% to $0.59 in pre-market trading after the company announced it entered into an exclusive Master Distribution Agreement with CBDAY Global. Under the agreement, CBDAY will exclusively sell Hempacco's line of hemp and CBD products in India and Thailand.
- MicroAlgo Inc. (NASDAQ: MLGO) shares rose 43.3% to $13.72 in pre-market trading. MicroAlgo shares jumped over 295% on Wednesday after the company announced it plans to establish a postgraduate training practice base.
- Oblong, Inc. (NASDAQ: OBLG) rose 32.5% to $0.1978 in pre-market trading after gaining over 3% on Wednesday.
- Altisource Asset Management Corporation(NYSE: AAMC) gained 31.5% to $4.43 in ...